Helix BioMedix (HXBM) Stock Price, News & Analysis

Company Overview

Helix BioMedix, Inc. operates as a specialty dermatology and consumer products skin health company in the United States. It develops and commercializes bioactive peptides, including anti-infective, anti-fungal, and anti-inflammatory peptides for the treatment of skin and wound infections, as well as for the prevention of staphylococcus aureus infections. The company also out-licenses its proprietary peptides to various entities. Helix BioMedix, Inc. was founded in 1988 and is headquartered in Bothell, Washington.

Key Stats

• Today's Range: $7.18 to $7.18
• 50-Day Range: $7.18 to $7.19
• 52-Week Range: $7.18 to $23.50
• Volume: N/A
• Average Volume: 125 shs
• Market Capitalization: $1.62 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

HXBM Stock Analysis - Frequently Asked Questions

How have HXBM shares performed this year?

Helix BioMedix's stock was trading at $8.00 on January 1st, 2025. Since then, HXBM shares have decreased by 10.3% and is now trading at $7.18.
View the best growth stocks for 2025 here.

How do I buy shares of Helix BioMedix?

Shares of HXBM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 3/25/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:HXBM
• CIK: N/A
• Web: www.helixbiomedix.com
• Phone: (425) 402-8400
• Fax: 425-806-2999
• Employees: 8
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 225,000
• Free Float: 204,000
• Market Cap: $1.62 million
• Optionable: Not Optionable
• Beta: 0.42